Literature DB >> 28854068

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

Torgrim Tandstad1, Christian K Kollmannsberger1, Bruce J Roth1, Claudio Jeldres1, Silke Gillessen1, Karim Fizazi1, Siamak Daneshmand1, William T Lowrance1, Nasser H Hanna1, Costantine Albany1, Richard Foster1, Gabriella Cohn Cedermark1, Darren R Feldman1, Thomas Powles1, Mark A Lewis1, Peter Scott Grimison1, Douglas Bank1, Christopher Porter1, Peter Albers1, Maria De Santis1, Sandy Srinivas1, George J Bosl1, Craig R Nichols1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28854068      PMCID： PMC5791831          DOI： 10.1200/JCO.2017.73.4723

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Patterns of performance of retroperitoneal lymph node dissections by American urologists: most retroperitoneal lymph node dissections in the United States are performed by low-volume surgeons.

Authors:  Andrew S Flum; Laurie Bachrach; Borko D Jovanovic; Irene B Helenowski; Sarah C Flury; Joshua J Meeks
Journal:  Urology       Date:  2014-10-11       Impact factor: 2.649

Review 2.  Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.

Authors:  G Cohn-Cedermark; O Stahl; T Tandstad
Journal:  Andrology       Date:  2014-10-01       Impact factor: 3.842

3.  Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer.

Authors:  E J Feuer; J Sheinfeld; G J Bosl
Journal:  J Natl Cancer Inst       Date:  1999-05-19       Impact factor: 13.506

4.  Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party.

Authors:  L Collette; R J Sylvester; S P Stenning; S D Fossa; G M Mead; R de Wit; P H de Mulder; N Neymark; E Lallemand; S B Kaye
Journal:  J Natl Cancer Inst       Date:  1999-05-19       Impact factor: 13.506

5.  Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.

Authors:  N Aass; O Klepp; E Cavallin-Stahl; O Dahl; H Wicklund; B Unsgaard; L Baldetorp; S Ahlström; S D Fosså
Journal:  J Clin Oncol       Date:  1991-05       Impact factor: 44.544

6.  Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.

Authors:  Peter Albers; Roswitha Siener; Susanne Krege; Hans-Uwe Schmelz; Klaus-Peter Dieckmann; Axel Heidenreich; Peter Kwasny; Maik Pechoel; Jan Lehmann; Sabine Kliesch; Kai-Uwe Köhrmann; Rolf Fimmers; Lothar Weissbach; Volker Loy; Christian Wittekind; Michael Hartmann
Journal:  J Clin Oncol       Date:  2008-05-05       Impact factor: 44.544

7.  Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture.

Authors:  L H Einhorn
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

8.  Management of malignant teratoma: does referral to a specialist unit matter?

Authors:  M J Harding; J Paul; C R Gillis; S B Kaye
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

9.  After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer.

Authors:  E J Feuer; C M Frey; O W Brawley; S G Nayfield; J B Cunningham; N L Geller; G J Bosl; B S Kramer
Journal:  J Clin Oncol       Date:  1994-02       Impact factor: 44.544

10.  Monitoring the delivery of cancer care: Commission on Cancer and National Cancer Data Base.

Authors:  Richelle T Williams; Andrew K Stewart; David P Winchester
Journal:  Surg Oncol Clin N Am       Date:  2012-04-17       Impact factor: 3.495
  10 in total
  17 in total

1.  Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors.

Authors:  C Albany; N Adra; A C Snavely; C Cary; T A Masterson; R S Foster; K Kesler; T M Ulbright; L Cheng; M Chovanec; F Taza; K Ku; M J Brames; N H Hanna; L H Einhorn
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

2.  Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.

Authors:  Ruichuan Shi; Weixing Chen; Bowen Yang; Jinglei Qu; Yu Cheng; Zhitu Zhu; Yu Gao; Qian Wang; Yunpeng Liu; Zhi Li; Xiujuan Qu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors.

Authors:  C Nichols; T Tandstad; W Lowrance; S Daneshmand
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

Review 4.  Surgical strategies for postchemotherapy testis cancer.

Authors:  Saum Ghodoussipour; Siamak Daneshmand
Journal:  Transl Androl Urol       Date:  2020-01

5.  Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline.

Authors:  Anupam Batra; Scott Ernst; Kylea Potvin; Ricardo Fernandes; Nicholas Power; James Vanhie; Eric Winquist
Journal:  Can Urol Assoc J       Date:  2019-07-23       Impact factor: 1.862

Review 6.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

7.  Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

Authors:  Stefanie Fischer; Torgrim Tandstad; Gabriella Cohn-Cedermark; Constance Thibault; Bruno Vincenzi; Dirk Klingbiel; Costantine Albany; Andrea Necchi; Angelika Terbuch; Anja Lorch; Jorge Aparicio; Axel Heidenreich; Marcus Hentrich; Matthew Wheater; Carl W Langberg; Olof Ståhl; Christian Daniel Fankhauser; Anis A Hamid; Konstantinos Koutsoukos; Jonathan Shamash; Jeff White; Carsten Bokemeyer; Jörg Beyer; Silke Gillessen
Journal:  J Clin Oncol       Date:  2019-12-26       Impact factor: 44.544

Review 8.  Adolescent and Young Adult Testicular Germ Cell Tumors: Special Considerations.

Authors:  Amanda F Saltzman; Nicholas G Cost
Journal:  Adv Urol       Date:  2018-01-31

9.  Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study.

Authors:  K-P Dieckmann; P Anheuser; M Kulejewski; R Gehrckens; B Feyerabend
Journal:  BMC Urol       Date:  2018-10-26       Impact factor: 2.264

10.  Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation.

Authors:  Zachary A K Frosch; Nicholas Illenberger; Nandita Mitra; Daniel J Boffa; Matthew A Facktor; Heidi Nelson; Bryan E Palis; Justin E Bekelman; Lawrence N Shulman; Samuel U Takvorian
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.